IACT Health

What IACT Health does

IACT Health, which operates under the brand and legal name Centricity Research, is a private clinical research site network founded in 2005 that conducts clinical trials on behalf of pharmaceutical sponsors and contract research organizations (CROs) across the United States and Canada. The company operates physical research sites under bilateral headquarters in Columbus, Georgia (USA) and Toronto, Ontario (Canada), and covers 35+ therapeutic areas including oncology, cardiology, pulmonology, and endocrinology. According to its own disclosures, the network has completed 3,500+ clinical studies, facilitated 100+ FDA and Health Canada drug approvals, and served 25,000+ patients cumulatively.

The business is structured as a professional-services clinical trial execution platform with two-sided demand. On the sponsor side, the company sells site capacity, patient enrollment, and study execution services to pharmaceutical companies and CROs through a dedicated business development function. On the patient side, it recruits participants through its own website (with paid study enrollment), a network of referring physicians, and free health-screening programs (FibroScan for liver health, peanut allergy screening, memory tests). Jeff Kingsley serves as CEO and Chair of the Board. The website-centricity brand is supported by separate US and Canadian social media accounts across Instagram, Facebook, LinkedIn, and TikTok, and contact paths include a US business line and a Canadian business line.

In October 2024 the company acquired North Carolina-based Lucas Research, extending its US southeastern footprint and adding therapeutic-area capabilities, consistent with an active site-consolidation strategy. Revenue, funding, and ownership details are not publicly disclosed; Lucas Research is listed as a wholly owned subsidiary with its brand retained.

Name

IACT Health

Legal name

Centricity Research

Website

https://iacthealth.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

101–250 employees

Short description

Centricity Research (operating as IACT Health) is a private, North American multi-site clinical research network that conducts trials across 35+ therapeutic areas for pharmaceutical sponsors and CROs, recruiting patients via its website, physician referrals, and free health screenings.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGACAE

Clinical Trial Site Operations & Study Coordination

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGAAAI

Patient Recruitment, Site Feasibility & Trial Enablement CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAL

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

Keywords

• Clinical trial services
• Contract research organization
• Patient recruitment
• Clinical study management
• Therapeutic research

Headquarters

HQ city

Columbus

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D, Others

Revenue model

1. Clinical Trial Site Services: Revenue generated from conducting clinical trials for pharmaceutical sponsors and CROs. The company operates research sites across the US and Canada where clinical trials are conducted, earning fees for patient enrollment, study execution, and data collection services.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

IACT Health (operating as Centricity Research) operates one of the largest clinical research site networks in North America, with sites across the US and Canada. The company conducts clinical trials for pharmaceutical sponsors and Contract Research Organizations (CROs) across 35+ therapeutic areas including oncology, cardiology, pulmonology, and endocrinology, earning fees for patient enrollment, study execution, and data collection. Patients can also apply directly through the company's website to join paid clinical research studies, with additional free health screening services such as FibroScan, peanut allergy screening, and memory tests.

Product overview

The company operates as a unified clinical research network offering end-to-end clinical trial services. Their portfolio encompasses patient recruitment and enrollment across 35+ therapeutic areas, free health screening services (including FibroScan for liver health, peanut allergy screening, and memory tests), and business development services for pharmaceutical sponsors and CROs. The network has conducted 3,500+ studies, facilitated 100+ FDA and Health Canada drug approvals, and serves 25,000+ patients across sites in the US and Canada.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Site Services for Sponsors and CROs End-to-end clinical trial execution services for pharmaceutical sponsors and Contract Research Organizations, including patient recruitment and enrollment, study protocol execution, and data collection across 35+ therapeutic areas at research sites in the US and Canada. The service is intended for drug development companies seeking to bring new medicines to market by leveraging an established multi-site network.
• Paid Clinical Research Study Enrollment Self-serve program through which individual patients and healthy volunteers apply via the company website to join paid clinical research studies across multiple therapeutic areas. Participants may receive compensation for their participation and access to free health screenings. The service feeds the sponsor pipeline and supports recruitment timelines.
• Free Health Screening Services Free health screening services offered to community members, including FibroScan liver assessments, peanut allergy screenings, and memory tests. These screenings serve as a community engagement and patient recruitment touchpoint for clinical research participation.

Quantifiable outcome

• 100+ FDA & Health Canada drug approvals facilitated
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Lucas ResearchcoreStrategic or Co-development Partner · 1 October 2024Centricity Research acquired North Carolina-based Lucas Research in October 2024, expanding its clinical research footprint across North America and adding to its therapeutic area capabilities. This acquisition strengthens the company's presence in the southeastern United States and broadens the range of conditions studied through their network.

Scale indicators5 records

Recent moves4 records

Expansion highlights6 records

Broad incumbents

• Medpace: Medpace is a global mid-sized CRO focused on full-service clinical development across multiple therapeutic areas. It competes with Centricity at the sponsor level for trial execution contracts and indirectly for the same patient populations.
• ICON plc: ICON plc is one of the largest global CROs after acquiring PRA Health Sciences, offering end-to-end clinical development services. It is a broader incumbent competing for large multi-region trials that may otherwise engage networks like Centricity.
• IQVIA: IQVIA is the largest global CRO with deep clinical trial site operations and real-world data capabilities. It is a broader incumbent that competes with Centricity for large sponsor programs, though it serves a much wider portfolio of services.

Direct peers

• Flourish Research: Flourish Research is an integrated clinical research site network built via acquisitions of regional sites, focused on multi-therapeutic outpatient trials. It is a direct comparable to Centricity's site-network model and patient recruitment approach.
• Benchmark Research: Benchmark Research is a clinical trial site network operating across multiple US states with multi-therapeutic capabilities, comparable to Centricity in scale, therapeutic breadth, and sponsor/CRO customer base.
• Velocity Clinical Research: Velocity is one of the largest integrated SMO/site networks in the US, acquired by GHO Capital in 2021 and continuing to consolidate regional research sites. It directly competes with Centricity for sponsor study placement across therapeutic areas.
• DM Clinical Research: DM Clinical Research operates a network of clinical trial sites in the southern US, conducting multi-specialty Phase I-IV trials for sponsors and CROs. It directly competes with Centricity for sponsor studies in overlapping regional markets.
• Meridien Research: Meridien Research is a multi-therapeutic clinical trial site network with locations across the southeastern US, matching Centricity's therapeutic breadth and patient-recruitment focus in overlapping geographies.
• Panther Clinical Research: Panther Clinical Research is a multi-site clinical research organization operating across the US with multi-therapeutic capabilities, directly comparable to Centricity's regional site network model and sponsor/CRO service offering.

Emerging players

• Elligo Health Research: Elligo is a technology-enabled SMO that brings clinical trials into physician practices and uses a patient identification platform. It competes with traditional site networks like Centricity by offering sponsors access to community-based patient populations without standing up dedicated sites.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/centricityusa
• LinkedInlinkedin.com/company/centricityresearch
• Instagraminstagram.com/centricityusa
• TikToktiktok.com/@centricityresearch
• Xx.com/IACTHealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IACT Health